Regression of cyclosporia-induced gingival overgrowth upon interruption of drug therapy
Related Experiment Video
Updated: Aug 25, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Hiru Mathur1, Antonio J Moretti, Catherine M Flaitz
1University of Texas Health Science Center, Houston Dental Branch, Department of Endodontics and Periodontics, USA.
Abstract:
Immunosuppressive therapy with cyclosporin has been known to cause gingival overgrowth in humans. It usually is not feasible to suspend this therapy to treat the adverse side effect. This case report describes a renal transplant patient who had used both cyclosporin and nifedipine for more than 10 years but had to discontinue immunosuppressive drug therapy due to organ rejection. Discontinuing therapy led to almost complete regression of the gingival overgrowth in a few months after interruption of cyclosporin therapy only. These findings suggest that the discontinuation of cyclosporin results in the reversal of gingival overgrowth without surgical intervention and may be the most definitive form of therapy for this condition in susceptible individuals as new drugs become available.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents